Photodynamic therapy for Barrett's oesophagus: How I do it
Summary
Endoscopic photodynamic therapy (PDT) for Barrett's oesophagus with high-grade dysplasia or early carcinoma is undertaken after full investigation. Endoscopic assessment is mandatory to determine the extent of the Barrett's segment and neoplastic changes. Photofrin at 2
mg/kg
bw is used, followed 24–72
h later by illumination of 630
nm light, 200
J/cm of lesion. The whole of the Barrett's segment should be exposed to illumination. Patients are followed up endoscopically at 3 months.
Keywords: Photodynamic therapy, Barrett's oesophagus
To access this article, please choose from the options below
PII: S1572-1000(06)00051-2
doi:10.1016/j.pdpdt.2006.03.002
© 2006 Elsevier B.V. All rights reserved.
